|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1975-10-30
|
|
pubmed:abstractText |
When rat parotid fragments that had been labelled with (32)P in vivo were exposed to high concentrations of acetylcholine, radioactivity was lost from phosphatidylinositol but not from other phospholipids. Simultaneously the concentration of phosphatidylinositol in the tissue decreased. If previously unlabelled tissue was incubated with (32)P(i) an increase in incorporation of radioactivity into phosphatidylinositol was observed during this decrease in concentration. The effects of acetylcholine were blocked by atropine, but not by tubocurarine. The response to acetylcholine was rapid, with up to one-third of the tissue's phosphatidylinositol disappearing within 5min. Similar effects were evoked by stimulation with methacholine and by high concentrations of tetramethylammonium ion; these responses were also atropine-sensitive and tubocurarine-insensitive. It is concluded that the event in inositol lipid metabolism that is affected by acetylcholine stimulation is removal of the phosphorylinositol group from the molecule; this is mediated through muscarinic cholinergic receptors. This is followed by a compensatory increase in the rate of synthesis of phosphatidylinositol, which has been described in detail in the past. These observations are compared with those of previous workers and are discussed in relation to the existing hypotheses relating to the significance of stimulus-provoked phosphatidylinositol turnover.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-13398961,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-13479413,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-13654383,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-13725923,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-13751549,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-14268509,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4122213,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4288210,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4291337,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4299946,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4304511,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4307914,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4310383,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4310384,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4318652,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4333513,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4339378,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4347533,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4348928,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4350000,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4350967,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4352717,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4352757,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4355238,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4357637,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4365258,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-4872349,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-5117567,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4377209-5337058
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0264-6021
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
142
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
583-90
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:4377209-Acetylcholine,
pubmed-meshheading:4377209-Animals,
pubmed-meshheading:4377209-Atropine,
pubmed-meshheading:4377209-Methacholine Compounds,
pubmed-meshheading:4377209-Parotid Gland,
pubmed-meshheading:4377209-Phosphatidylinositols,
pubmed-meshheading:4377209-Phospholipids,
pubmed-meshheading:4377209-Physostigmine,
pubmed-meshheading:4377209-Quaternary Ammonium Compounds,
pubmed-meshheading:4377209-Rats,
pubmed-meshheading:4377209-Receptors, Cholinergic,
pubmed-meshheading:4377209-Time Factors,
pubmed-meshheading:4377209-Tubocurarine
|
|
pubmed:year |
1974
|
|
pubmed:articleTitle |
Breakdown of phosphatidylinositol provoked by muscarinic cholinergic stimulation of rat parotid-gland fragments.
|
|
pubmed:publicationType |
Journal Article
|
